| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Jin Yang | |
| Jin Yu | |||
| Ya-Qin Huang | |||
| Yin-Jie Su | |||
| P2860 | cites work | A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains | Q21266548 |
| Global cancer statistics | Q22241238 | ||
| The Nuclear-Retained Noncoding RNA MALAT1 Regulates Alternative Splicing by Modulating SR Splicing Factor Phosphorylation | Q24297656 | ||
| The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma. | Q24535316 | ||
| Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene | Q24632383 | ||
| Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a | Q24633736 | ||
| [Diagnosis and treatment of xanthogranulomatous prostatitis: a case report and review of the literature]. | Q53118730 | ||
| Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: long-term follow-up of the SPCG-6 study. | Q53535568 | ||
| Long noncoding RNA PCA3 gene promoter region is related to the risk of prostate cancer on Chinese males. | Q54183002 | ||
| Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. | Q54251772 | ||
| Visiting "noncodarnia". | Q55057229 | ||
| Re: Hessels D, Klein Gunnewiek JMT, van Oort I, Karthaus HFM, van Leenders GJL, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003;44:8?16 | Q62632515 | ||
| PSA velocity for the diagnosis of early prostate cancer. A new concept | Q71604655 | ||
| Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer | Q73477389 | ||
| The expression of the imprinted genes H19 and IGF-2 in choriocarcinoma cell lines. Is H19 a tumor suppressor gene? | Q73558651 | ||
| The epidemiology of prostate cancer part I: descriptive epidemiology | Q77701698 | ||
| Quality of life and satisfaction with outcome among prostate-cancer survivors | Q80917895 | ||
| Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance | Q82878808 | ||
| Association between lncrna PCGEM1 polymorphisms and prostate cancer risk | Q86266745 | ||
| Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy. | Q38023022 | ||
| Long noncoding RNA: an emerging paradigm of cancer research | Q38077502 | ||
| LncRNA: a link between RNA and cancer | Q38243587 | ||
| Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis | Q38304774 | ||
| Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells | Q38340382 | ||
| Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility | Q38947097 | ||
| lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. | Q38978723 | ||
| Linc00963: a novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence. | Q39009233 | ||
| Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer | Q39145196 | ||
| Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines | Q39151560 | ||
| Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer | Q39156237 | ||
| miR-205 regulates basement membrane deposition in human prostate: implications for cancer development | Q39354108 | ||
| The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor | Q39408936 | ||
| DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer | Q39689415 | ||
| Quantitative multi-gene expression profiling of primary prostate cancer | Q40241443 | ||
| Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure). | Q44502866 | ||
| Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples. | Q48056452 | ||
| The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines | Q24655583 | ||
| PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer | Q24682755 | ||
| Long non-coding RNA: a new player in cancer | Q27000700 | ||
| Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. | Q27824849 | ||
| Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 | ||
| Cancer statistics, 2014 | Q27861018 | ||
| The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities | Q28297958 | ||
| MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer | Q29620125 | ||
| Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer | Q30525287 | ||
| PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer | Q33565650 | ||
| lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. | Q33666551 | ||
| The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer | Q33688877 | ||
| DD3: a new prostate-specific gene, highly overexpressed in prostate cancer | Q33884277 | ||
| Androgen deprivation therapy for prostate cancer: long-term safety and patient outcomes | Q33890406 | ||
| DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer | Q34206957 | ||
| New targets for therapy in prostate cancer: differential display code 3 (DD3PCA3), a highly prostate cancer–specific gene | Q34275522 | ||
| Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients | Q34290030 | ||
| In vivo amplification of the androgen receptor gene and progression of human prostate cancer | Q34314274 | ||
| Long noncoding RNAs as putative biomarkers for prostate cancer detection | Q34409743 | ||
| Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. | Q34506320 | ||
| Cancer survival in five continents: a worldwide population-based study (CONCORD). | Q34798041 | ||
| A long noncoding RNA connects c-Myc to tumor metabolism. | Q34830610 | ||
| miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. | Q34952175 | ||
| Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer | Q34957004 | ||
| A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer | Q35022483 | ||
| Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression | Q35154249 | ||
| RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings | Q35932349 | ||
| Radical prostatectomy versus observation for localized prostate cancer | Q36194308 | ||
| The hallmarks of cancer: a long non-coding RNA point of view. | Q36391951 | ||
| Antisense now makes sense: dual modulation of androgen-dependent transcription by CTBP1-AS | Q36923825 | ||
| Prostate-specific antigen mass and free prostate-specific antigen mass for predicting the prostate volume of korean men with biopsy-proven benign prostatic hyperplasia | Q37172478 | ||
| The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex | Q37266000 | ||
| Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer | Q37718438 | ||
| Novel therapeutic strategies for castration resistant prostate cancer: inhibition of persistent androgen production and androgen receptor mediated signaling | Q37829042 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| antineoplastic | Q2853144 | ||
| long non-coding RNA | Q15087973 | ||
| prostate neoplasm | Q56014511 | ||
| tumor biomarker | Q66205818 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 13322-13338 | |
| P577 | publication date | 2015-06-11 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer | |
| P478 | volume | 16 |
| Q53032370 | Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer. |
| Q38878172 | Circulating long noncoding RNAs as novel biomarkers of human diseases |
| Q57112724 | Detecting long non-coding RNA biomarkers in prostate cancer liquid biopsies: Hype or hope? |
| Q47428589 | Differential expression of long non-coding RNAs in patients with tuberculosis infection |
| Q94453306 | Downregulated lncRNA UCA1 accelerates proliferation and migration of vascular smooth muscle cells by epigenetic regulation of MMP9 |
| Q38734618 | Exome-based genome-wide association study and risk assessment using genetic risk score to prostate cancer in the Korean population |
| Q49491067 | Expression status and clinical significance of lncRNA APPAT in the progression of atherosclerosis |
| Q53779715 | Expressional profiling of prostate cancer risk SNPs at 11q13.5 identifies DGAT2 as a new target gene. |
| Q39032235 | HOTAIR role in melanoma progression and its identification in the blood of patients with advanced disease |
| Q47145939 | LncRNA XIST acts as a tumor suppressor in prostate cancer through sponging miR-23a to modulate RKIP expression |
| Q33707998 | LncRNA-AF113014 promotes the expression of Egr2 by interaction with miR-20a to inhibit proliferation of hepatocellular carcinoma cells |
| Q92073772 | LncRNAs: The Regulator of Glucose and Lipid Metabolism in Tumor Cells |
| Q58770077 | Long non-coding RNA NAP1L6 promotes tumor progression and predicts poor prognosis in prostate cancer by targeting Inhibin-β A |
| Q64240847 | Long non-coding RNAs: Functional regulatory players in breast cancer |
| Q53132551 | Long noncoding RNA POU6F2-AS2 is associated with oesophageal squamous cell carcinoma. |
| Q39110866 | Long noncoding RNAs (lncRNAs) in triple negative breast cancer |
| Q38639536 | Long noncoding RNAs and tumorigenesis: genetic associations, molecular mechanisms, and therapeutic strategies |
| Q37465789 | Microarray Expression Profiling of Long Non-Coding RNAs Involved in Nasopharyngeal Carcinoma Metastasis. |
| Q39368869 | Multiple functions of long non-coding RNAs in oxidative stress, DNA damage response and cancer progression. |
| Q57043976 | Specific expression of lncRNA RP13-650J16.1 and TCONS_00023979 in prostate cancer |
| Q41339824 | The prognostic value of long noncoding RNAs in prostate cancer: a systematic review and meta-analysis. |
| Q35854622 | Urinary Biomarkers for Prostate Cancer |
| Q38701014 | lncRNA C22orf32-1 contributes to the tumorigenesis of nasopharyngeal carcinoma |
Search more.